Iceland· IS-970108
Alutard SQ (Betula verrucosa)
A baumpollen product containing betula verrucosa, registered in Iceland by ALK-Abelló A/S. The same ATC class is registered in 12 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Baumpollen is registered in 12 of 19 countries.
Countries holding a registration under ATC V01AA05 (baumpollen), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Baumpollen · ATC V01AA05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Betula verrucosa
- Manufacturer
- ALK-Abelló A/S
- Country
- Iceland (IS)
- ATC code
- V01AA05
- ATC class
- Baumpollen
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Baumpollen in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenItulazax 12 SQ-Bet Frystorkad sublingual tablettMedartuum AB
- SwitzerlandAlutard SQ Betula verrucosa
- GermanyAlk-Prick SqAlk-Abelló Arzneimittel Gmbh
- United KingdomSilver Birch (Betula verrucosa) pollen 50HEP/ml solution for skin prick testInmunotek
- NorwayItulazax2care4 ApS
- PolandItulazaxAlk-Abello A/S
- CanadaITULATEKALK-ABELLO A/S
- IrelandITULAZAX 12 SQ-Bet sublingual lyophilisateALK-Abello A/S
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fdb7f54e-81ea-4d02-a550-fd53db698717 GET /v1/drugs/fdb7f54e-81ea-4d02-a550-fd53db698717?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, dreifa",
"source": "lyfjastofnun",
"atc_raw": "V01AA05",
"marketed": true,
"strength": null,
"ma_number": "970108",
"substance": "Betula verrucosa",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í ofnæmis- og ónæmislækningum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "36285"
}See everything about baumpollen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.